Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy.
Saved in:
| Title: | Interleukin 1β receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy. |
|---|---|
| Authors: | Mahmoud LM; Department of Physiology, Faculty of Medicine, Cairo University, Giza, Egypt., Mageed AAAA; Department of Physiology, Faculty of Medicine, Cairo University, Giza, Egypt. aya.abdelmageed@kasralainy.edu.eg., Saadallah JM; Department of Physiology, Faculty of Medicine, Cairo University, Giza, Egypt., Youssef MF; Department of Histology, Faculty of Medicine, Cairo University, Giza, Egypt., Rashed LA; Department of Biochemistry, Faculty of Medicine, Cairo University, Giza, Egypt., Ammar HI; Department of Physiology, Faculty of Medicine, Cairo University, Giza, Egypt. |
| Source: | Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Oct; Vol. 397 (10), pp. 8023-8041. Date of Electronic Publication: 2024 May 22. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0326264 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1912 (Electronic) Linking ISSN: 00281298 NLM ISO Abbreviation: Naunyn Schmiedebergs Arch Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-1912 |
|---|---|
| DOI: | 10.1007/s00210-024-03152-1 |
